D.E. Shaw & Co
IHE icon

D.E. Shaw & Co’s iShares US Pharmaceuticals ETF IHE Stock Holding History

D.E. Shaw & Co’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6,040
Closed -$397K – 4468
2024
Q4 		$397K Buy
+6,040
New +$416K ﹤0.01% 3752
2024
Q3 		– Sell
-5,211
Closed -$346K – 4688
2024
Q2 		$346K Buy
+5,211
New +$341K ﹤0.01% 3819

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

D.E. Shaw & Co's IHE Position: Q1 2025 in Review

D.E. Shaw & Co sold out of iShares US Pharmaceuticals ETF (IHE) in Q1 2025, closing a stake of 6,040 shares — an estimated $397K sold.

D.E. Shaw & Co first reported a position in IHE in Q2 2024 and held it in 2 quarters. The position peaked at $397K in Q4 2024. 149 funds tracked by Wall St. Rank hold IHE as of Q1 2025.

  • D.E. Shaw & Co reported no remaining iShares US Pharmaceuticals ETF position as of Q1 2025 after selling out during the quarter.
  • D.E. Shaw & Co sold 6,040 iShares US Pharmaceuticals ETF shares in Q1 2025, an estimated $397K.
  • D.E. Shaw & Co first reported a position in iShares US Pharmaceuticals ETF in Q2 2024 and held it in 2 quarters.
  • D.E. Shaw & Co's iShares US Pharmaceuticals ETF position peaked at $397K in Q4 2024.
  • 149 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2025.

Based on D.E. Shaw & Co's 13F filing for Q1 2025, filed 15 May 2025.